Tim Lee | Senior Director of Investor Relations |
Jan Mikkelsen | President and Chief Executive Officer |
Scott Smith | Executive Vice President and Chief Financial Officer |
Joe Kelly | Senior Vice President, Head of Commercial Endocrinology |
Mads Bodenhoff | Senior Vice President, Head of Finance |
Jessica Fye | JP Morgan |
Tazeen Ahmad | Bank of America |
David Lebovitz | Citi |
Paul Choi | Goldman Sachs |
Li Watsek | Cantor |
Derek Archila | Wells Fargo |
Leland Gershell | Oppenheimer |
Vikram Purohit | Morgan Stanley |
Joseph Schwartz | SVB Securities |
Andreas Argyrides | Wedbush |
Caroline Palomeque | Berenberg |
Thank you for standing by and welcome to the Q1 2023 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session [Operator Instructions] As a reminder today's call is being recorded.
I would now like to turn the call over to your host Mr. Tim Lee, Senior Director of Investor Relations.